Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension

• Main Authors: I. M. Mikheytseva (Author), G. S. Grygorieva (Author), N. V. Pasyechnikova (Author), S. G. Kolomiichuk (Author), T. I. Siroshtanenko (Author), N. F. Konakhovych (Author)
• Format: Book
• Published: Ukrainian Society of Ophthalmologists, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Prostaglandin analogs (e.g., latanoprost) are the first-line therapy for glaucoma. These medications, however, have a short antihypertensive effect due to low penetration of topical drug across the corneal epithelium, which causes the need for their daily application for a long time. The...